Literature DB >> 10971608

Opsoclonus-myoclonus syndrome: gabapentin as a new therapeutic proposal.

R Moretti, P Torre, R M Antonello, D Nasuelli, G Cazzato.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10971608     DOI: 10.1046/j.1468-1331.2000.00091.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


× No keyword cloud information.
  6 in total

1.  Paraneoplastic Opsoclonus-Myoclonus Syndrome: initial presentation of non-Hodgkins lymphoma.

Authors:  Ashwani Kumar; Walter A Lajara-Nanson; Robert W Neilson
Journal:  J Neurooncol       Date:  2005-05       Impact factor: 4.130

2.  Clinical and Immunological Features of Opsoclonus-Myoclonus Syndrome in the Era of Neuronal Cell Surface Antibodies.

Authors:  Thaís Armangué; Lidia Sabater; Estefanía Torres-Vega; Eugenia Martínez-Hernández; Helena Ariño; Mar Petit-Pedrol; Jesús Planagumà; Luis Bataller; Josep Dalmau; Francesc Graus
Journal:  JAMA Neurol       Date:  2016-04       Impact factor: 18.302

3.  Opsoclonus-myoclonus syndrome in patients with locked-in syndrome: a therapeutic porthole with gabapentin.

Authors:  Francesca Pistoia; Massimiliano Conson; Marco Sarà
Journal:  Mayo Clin Proc       Date:  2010-06       Impact factor: 7.616

4.  Gaze-holding and anti-GAD antibody: prototypic heterogeneous motor dysfunction in immune disease.

Authors:  Wanchat Theeranaew; Fajun Wang; Fatema F Ghasia; George Wilmot; Aasef G Shaikh
Journal:  Cerebellum       Date:  2021-05-11       Impact factor: 3.847

5.  Adult-onset opsoclonus-myoclonus-ataxia syndrome as a manifestation of brazilian lyme disease-like syndrome: a case report and review of literature.

Authors:  Angelina Maria Martins Lino; Raphael Ribeiro Spera; Fernando Peixoto Ferraz de Campos; Christian Henrique de Andrade Freitas; Márcio Ricardo Taveira Garcia; Leonardo da Costa Lopes; Aleksander Snioka Prokopowitsch
Journal:  Autops Case Rep       Date:  2014-03-31

Review 6.  Update on opsoclonus-myoclonus syndrome in adults.

Authors:  Sun-Young Oh; Ji-Soo Kim; Marianne Dieterich
Journal:  J Neurol       Date:  2018-11-27       Impact factor: 4.849

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.